A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis.
A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis.
复制标题
DOI:
10.1038/ncb3445
复制
发表时间:
2017-01
影响因子:
21.3
通讯作者:
Lin HK
中科院分区:
文献类型:
--
作者:
Rezaeian AH;Li CF;Wu CY;Zhang X;Delacerda J;You MJ;Han F;Cai Z;Jeong YS;Jin G;Phan L;Chou PC;Lee MH;Hung MC;Sarbassov D;Lin HK
The understanding of how hypoxia stabilizes and activates HIF1α in the nucleus with related oncogenic signals can revolutionize targeted therapy for cancers. Here, we find that histone H2AX displays oncogenic activity by serving as a crucial regulator of HIF1α signalling. H2AX interacts with and prevents HIF1α from degradation and nuclear export upon hypoxia for transcriptional activation in a VHL-independent manner. We show that monoubiquitination and phosphorylation of H2AX, which are strictly mediated by hypoxia-induced E3 ligase activity of TRAF6 and ATM, critically regulate HIF1α-driven tumourigenesis. Importantly, TRAF6 and γH2AX are overexpressed in human breast cancer, correlate with activation of HIF1α signalling and predict metastatic outcome. Thus, TRAF6 and H2AX overexpression and γH2AX-mediated HIF1α enrichment in the nucleus of cancer cells lead to overactivation of HIF1α-driven tumourigenesis, glycolysis and metastasis. Our findings suggest that TRAF6-mediated monoubiquitination and subsequent phosphorylation of H2AX may serve as potential means for cancer diagnosis and therapy.